INmune Bio

INmune Bio Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 4
Employees
  • Stock Symbol
  • INMB
Stock Symbol
  • Share Price
  • $7.00
  • (As of Friday Closing)

INmune Bio General Information

Description

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products include INBO3, XPro1595, LIVNate, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 1224 Prospect Street
  • Suite 150 La Jolla
  • San Diego, CA 92037
  • United States
+1 (858) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

INmune Bio Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.00 $6.10 $2.20 - $10.35 $75.7M 10.8M 56.7K -$0.73

INmune Bio Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 28,960 55,277
Revenue 0 0 0 0
EBITDA (7,937) (7,756) (12,440)
Net Income (7,848) (7,678) (12,440) (831)
Total Assets 23,678 24,470 17,363 18,413
Total Debt 173 168 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

INmune Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore INmune Bio‘s full profile, request access.

Request a free trial

INmune Bio Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Fate Therapeutics Formerly VC-backed San Diego, CA 000 00000 00000000000 00000
000 000000000 Corporation Gainesville, FL 0 00.000 000000000000 00.000
0000000 Formerly PE-Backed Beijing, China 0000 00.000 000000000 00.000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
000000000 00000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000

INmune Bio Executive Team (3)

Name Title Board Seat Contact Info
Raymond Tesi MD Chief Executive Officer & Chairman
David Moss Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Mark Lowdell Ph.D Chief Scientific Officer

INmune Bio Board Members (7)

To view INmune Bio‘s full board member team, request access »
Name Representing Role Since
David Szymkowski Ph.D INmune Bio Board Member 000 0000
Edgardo Baracchini Ph.D Self Board Member 000 0000
Kelly Ganjei Self Board Member 000 0000
Raymond Tesi MD INmune Bio Chief Executive Officer & Chairman 000 0000
Scott Juda INmune Bio Board Member 000 0000